1
|
Saczkowski R, Spada S, Hromadnik K. Perfusionist removal of intra-aortic balloon pump catheters improves efficiency without an increase in complication rates. Perfusion 2024; 39:506-513. [PMID: 36749309 DOI: 10.1177/02676591221149858] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
INTRODUCTION The intra-aortic balloon pump (IABP) is one of the most utilized cardiac assist devices. Patients receiving IABP therapy are typically managed in high acuity clinical care areas with limited bed space and high demand. Our center instituted a certified clinical perfusionist (CCP) led initiative to remove IABP catheters in order to reduce IABP therapy time, hasten removal and improve efficiency. METHODS The purpose of the study is to compare outcomes for IABP removal by a certified clinical perfusionist to a physician. The primary outcome measures were site hematoma score and limb related complications. A survey was submitted to bedside nurses, managers/patient care coordinators, CCP's and physicians. The IABP quality assurance database was interrogated for the study. RESULTS There were 350 patients eligible for inclusion. The cohort was well balanced between CCP (n = 284) and physician (n = 66) groups for patient demographics, indication, insertion specifics and type of medical intervention. The majority of patients had no bruise or hematoma with perfusionist (n = 246, 87%) or physician (n = 58, 88%) (p = 0.78) removal. The physician group demonstrated a higher rate of grade 3 hematomas (p = 0.03). There was no statistically significant difference between CCP and physician groups for limb complications and mortality. Survey results showed an improved efficiency in bed space allocation, physician workload and a decreased IABP support time. CONCLUSION There is no difference in limb complications between perfusionist and physician removal of IABP catheters. The survey demonstrate an improvement in resource allocation and efficiency. A perfusionist led IABP removal program can be done safely and may help improve program efficiency.
Collapse
Affiliation(s)
- Richard Saczkowski
- Interior Health Cardiac Sciences Program, Department of Cardiovascular Perfusion, Kelowna General Hospital, Kelowna, BC, Canada
| | - Saverio Spada
- Interior Health Cardiac Sciences Program, Department of Cardiovascular Perfusion, Kelowna General Hospital, Kelowna, BC, Canada
| | - Kris Hromadnik
- Department of Cardiovascular Perfusion, Queen Elizabeth II Hospital, Halifax, NS, Canada
| |
Collapse
|
2
|
Ramirez-Ramos CF, Aranzazu-Uribe M, Pamplona A, Gallego-Muñoz C, Uribe-Molano JD, Muñoz Sierra JG, Vanegas-Cardona DM, Tenorio-Mejia CA, Eusse-Gomez CA, Uribe-Londoño CE. [Intra-aortic balloon counterpulsation placed through the subclavian artery as a bridge to heart transplantation. Case report]. ARCHIVOS PERUANOS DE CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR 2021; 2:135-140. [PMID: 37727800 PMCID: PMC10506553 DOI: 10.47487/apcyccv.v2i2.134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/18/2021] [Accepted: 05/19/2021] [Indexed: 09/21/2023]
Abstract
Advanced heart failure is a major health problem for which heart transplantation or left ventricular assist devices are the only effective treatments. Intra-aortic balloon pump inserted using femoral artery access as a bridge to heart transplantation is still frequently used, but has the disadvantage of limiting the patient's movements, hence exposing him or her to the hazards of immobility and threatening the success of the procedure or hindering recovery. Access through the subclavian artery has become an attractive alternative since it doesn't impair the patient's mobility, and there is increasing evidence supporting its use. We present the first case of subclavian counterpulsation balloon implantation in a cardiovascular care center in Colombia.
Collapse
Affiliation(s)
- Cristhian Felipe Ramirez-Ramos
- Departamento de Cardiología Clínica, Clínica CardioVID y Universidad Pontificia Bolivariana. Medellín, Colombia. Universidad Pontificia BolivarianaDepartamento de Cardiología ClínicaClínica CardioVID y Universidad Pontificia BolivarianaMedellínColombia
| | - Mateo Aranzazu-Uribe
- Departamento de Medicina Interna, Universidad Pontificia Bolivariana. Medellín, Colombia. Médico.Universidad Pontificia BolivarianaDepartamento de Medicina InternaUniversidad Pontificia BolivarianaMedellínColombia
| | - Alejandra Pamplona
- Servicio de Urgencias Cardiovasculares, Clínica CardioVID. Medellín, Colombia. Servicio de Urgencias CardiovascularesClínica CardioVIDMedellínColombia
| | - Catalina Gallego-Muñoz
- Departamento de Cardiología Clínica, Cuidado Intensivo Coronario y Falla Cardiaca, Clínica CardioVID y Universidad Pontificia Bolivariana. Medellín, Colombia. Universidad Pontificia BolivarianaDepartamento de Cardiología ClínicaCuidado Intensivo Coronario y Falla CardiacaClínica CardioVID y Universidad Pontificia BolivarianaMedellínColombia
| | - Juan David Uribe-Molano
- Departamento de medicina critica y cuidado intensivo cardiovascular, Clìnica cardiioVID. Departamento de medicina critica y cuidado intensivo cardiovascularClìnica cardiioVID
| | - Juan Gonzalo Muñoz Sierra
- Departamento de Radiología Intervencionista y Neuro-radiología, Clínica CardioVID. Medellín, Colombia. Departamento de Radiología Intervencionista y Neuro-radiologíaClínica CardioVIDMedellínColombia
| | - Diego Mauricio Vanegas-Cardona
- Departamento de Cardiología Intervencionista y Hemodinámica Cardiovascular. Clínica CardioVID. Medellín, Colombia. Departamento de Cardiología Intervencionista y Hemodinámica CardiovascularClínica CardioVIDMedellínColombia
| | - Carlos Alberto Tenorio-Mejia
- Departamento de Cardiología Intervencionista y Hemodinámica Cardiovascular. Clínica CardioVID. Medellín, Colombia. Departamento de Cardiología Intervencionista y Hemodinámica CardiovascularClínica CardioVIDMedellínColombia
| | - Carlos Alberto Eusse-Gomez
- Departamento de Cardiología Intervencionista y Hemodinámica Cardiovascular. Clínica CardioVID. Medellín, Colombia. Departamento de Cardiología Intervencionista y Hemodinámica CardiovascularClínica CardioVIDMedellínColombia
| | - Carlos Esteban Uribe-Londoño
- Departamento de Cardiología Intervencionista y Hemodinámica Cardiovascular. Clínica CardioVID. Medellín, Colombia. Departamento de Cardiología Intervencionista y Hemodinámica CardiovascularClínica CardioVIDMedellínColombia
| |
Collapse
|
3
|
Kapur NK, Whitehead EH, Thayer KL, Pahuja M. The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety. F1000Res 2020; 9. [PMID: 32765837 PMCID: PMC7391013 DOI: 10.12688/f1000research.25518.1] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/20/2020] [Indexed: 12/16/2022] Open
Abstract
Acute mechanical circulatory support (MCS) devices are widely used in cardiogenic shock (CS) despite a lack of high-quality clinical evidence to guide their use. Multiple devices exist across a spectrum from modest to complete support, and each is associated with unique risks. In this review, we summarize existing data on complications associated with the three most widely used acute MCS platforms: the intra-aortic balloon pump (IABP), Impella systems, and veno-arterial extracorporeal membrane oxygenation (VA-ECMO). We review evidence from available randomized trials and highlight challenges comparing complication rates from case series and comparative observational studies where a lack of granular data precludes appropriate matching of patients by CS severity. We further offer a series of best practices to help shock practitioners minimize the risk of MCS-associated complications and ensure the best possible outcomes for patients.
Collapse
Affiliation(s)
- Navin K Kapur
- The Cardiovascular Center for Research and Innovation, Tufts Medical Center, Boston, MA, USA
| | - Evan H Whitehead
- The Cardiovascular Center for Research and Innovation, Tufts Medical Center, Boston, MA, USA
| | - Katherine L Thayer
- The Cardiovascular Center for Research and Innovation, Tufts Medical Center, Boston, MA, USA
| | - Mohit Pahuja
- Division of Cardiology, Detroit Medical Center/Wayne State University School of Medicine, Detroit, MI, USA
| |
Collapse
|
4
|
de Jong MM, Lorusso R, Al Awami F, Matteuci F, Parise O, Lozekoot P, Bonacchi M, Maessen JG, Johnson DM, Gelsomino S. Vascular complications following intra-aortic balloon pump implantation: an updated review. Perfusion 2017; 33:96-104. [PMID: 28816093 PMCID: PMC5844455 DOI: 10.1177/0267659117727825] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
Background: The use of the intra-aortic balloon pump (IABP) as a support device remains controversial due to the fact that a number of studies have shown no benefit in end mortality whilst using this device. One of the reasons for this could be the increase in vascular complications when using the pump. Therefore, the aim of the present review was to assess the current literature available with regards to IABP vascular complications during the clinical situation. Methods: A literature search was performed, searching for IABP complications in adult human studies between 1990 and 2016. Results: A total of 20 reports were identified as fitting the criteria of this study. The majority of vascular complications were limb ischemia, bleeding or mesenteric ischemia. The overall incidence of vascular complications ranged from 0.94% to 31.1%. Diabetes, peripheral vascular disease and hypertension, as well as smoking were all identified as risk factors for complications following IABP. Furthermore, studies supported the use of sheathless balloon insertion to reduce the risk of complications. Conclusion: Major vascular complications, including limb and mesenteric ischemia as well as bleeding and hemorrhage, have been associated with IABP. However, the incidence of these complications was generally low. Further studies are still required to truly understand the risk/benefit associated with the use of IABP.
Collapse
Affiliation(s)
- Monique M de Jong
- 1 Department of Cardiothoracic Surgery, Cardiovascular Research Institute Maastricht-CARIM, Maastricht, The Netherlands
| | - Roberto Lorusso
- 1 Department of Cardiothoracic Surgery, Cardiovascular Research Institute Maastricht-CARIM, Maastricht, The Netherlands
| | - Fatima Al Awami
- 1 Department of Cardiothoracic Surgery, Cardiovascular Research Institute Maastricht-CARIM, Maastricht, The Netherlands
| | - Francesco Matteuci
- 1 Department of Cardiothoracic Surgery, Cardiovascular Research Institute Maastricht-CARIM, Maastricht, The Netherlands
| | - Orlando Parise
- 1 Department of Cardiothoracic Surgery, Cardiovascular Research Institute Maastricht-CARIM, Maastricht, The Netherlands
| | - Pieter Lozekoot
- 1 Department of Cardiothoracic Surgery, Cardiovascular Research Institute Maastricht-CARIM, Maastricht, The Netherlands
| | - Massimo Bonacchi
- 2 Section of Cardiac Surgery, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
| | - Jos G Maessen
- 1 Department of Cardiothoracic Surgery, Cardiovascular Research Institute Maastricht-CARIM, Maastricht, The Netherlands
| | - Daniel M Johnson
- 1 Department of Cardiothoracic Surgery, Cardiovascular Research Institute Maastricht-CARIM, Maastricht, The Netherlands
| | - Sandro Gelsomino
- 1 Department of Cardiothoracic Surgery, Cardiovascular Research Institute Maastricht-CARIM, Maastricht, The Netherlands
| |
Collapse
|
5
|
The Subclavian Intraaortic Balloon Pump: A Compelling Bridge Device for Advanced Heart Failure. Ann Thorac Surg 2015; 100:2151-7; discussion 2157-8. [DOI: 10.1016/j.athoracsur.2015.05.087] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/06/2015] [Revised: 05/11/2015] [Accepted: 05/15/2015] [Indexed: 11/22/2022]
|
6
|
Böning A, Buschbeck S, Roth P, Scheibelhut C, Bödeker RH, Brück M, Niemann B. IABP before cardiac surgery: clinical benefit compared to intraoperative implantation. Perfusion 2012; 28:103-8. [DOI: 10.1177/0267659112471577] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Background: The aim of this study was to determine whether preoperative compared to intraoperative intra-aortic balloon counterpulsation (IABP) is advantageous regarding 30-day and 2-year survival in high-risk patients (acute myocardial infarction, severely impaired left ventricular ejection fraction (LVEF), low output syndrome) undergoing coronary surgery. Methods: In the years 2004 to 2008, 156 consecutive patients undergoing coronary surgery with IABP support (119 preoperative, 37 intraoperative IABP) were observed. Applying Fisher’s exact test, as well as Wilcoxon and median tests, possible group differences were evaluated. After univariate analysis, models of logistic regression and Cox-regression were built. Results: Preoperative hemodynamic state and risk profile of the two patient groups were comparable: patients with preoperative IABP showed a similar level of urgency (21.9% vs. 18.9% emergencies), cardiogenic shock (8.4% vs. 10.8%), inotropes (8.4% vs. 8.1%), impaired LVEF (30.3% vs. 29.7%) and ventilation (5.9% vs. 5.4%) compared to patients with intraoperative IABP. Nevertheless, patients with intraoperative IABP demonstrated a significantly higher 30-day mortality rate (37.8% vs. 5.9%) and 2-year mortality rate (54.0% vs. 18.1%) compared to patients with preoperative IABP. Logistic regression revealed that patients with intraoperative IABP have a 16-times higher 30-day mortality rate after coronary surgery (OR: 16.386, 95% CI: 4.858-55.266) than patients with preoperative IABP. Two-year mortality (OR: 9.317, 95% CI: 3.430 to 25.311) and survival time were significantly better in patients with preoperative IABP therapy. Conclusion: Considering the significant benefit for patients with preoperative compared to intraoperative IABP and the absence of vascular problems after IABP insertion, the results of this study indicate a more liberal indication for IABP in high-risk patients before coronary bypass surgery.
Collapse
Affiliation(s)
- A Böning
- Department of Cardiovascular Surgery, University Hospital Giessen, Giessen, Germany
| | - S Buschbeck
- Department of Cardiovascular Surgery, University Hospital Giessen, Giessen, Germany
| | - P Roth
- Department of Cardiovascular Surgery, University Hospital Giessen, Giessen, Germany
| | - C Scheibelhut
- Department of Medical Statistics, Justus Liebig University, Giessen, Germany
| | - RH Bödeker
- Department of Medical Statistics, Justus Liebig University, Giessen, Germany
| | - M Brück
- Department of Cardiology and Nephrology, Lahn-Dill-Kliniken, Wetzlar, Germany
| | - B Niemann
- Department of Cardiovascular Surgery, University Hospital Giessen, Giessen, Germany
| |
Collapse
|
7
|
Davidavicius G, Godino C, Shannon J, Takagi K, Bertoldi L, Mussardo M, Chieffo A, Arioli F, Ielasi A, Montorfano M, Latib A, Colombo A. Incidence of Overall Bleeding in Patients Treated With Intra-Aortic Balloon Pump During Percutaneous Coronary Intervention. JACC Cardiovasc Interv 2012; 5:350-7. [DOI: 10.1016/j.jcin.2011.12.012] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/27/2011] [Revised: 11/30/2011] [Accepted: 12/08/2011] [Indexed: 10/28/2022]
|